MoneyWorks4Me

Transpact Enterprises informs about disclosure on material impact of covid-19

11 Aug 2020 Evaluate

Pursuant to SEBI Circular SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020, Transpact Enterprises has informed that it has enclosed disclosure on material impact of COVID-19 pandemic on the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Lenskart Solutions 675.90
Poly Medicure 1714.40
Molbio Diagnostics 1246.20
Laxmi Dental 196.75
GKB Ophthalmics 66.09
View more..